Preoperative Home-based Multimodal Prehabilitation Based on 5G + Artificial Intelligence Mobile Health

Starting soon · Not applicable

Conditions studied: Gastric Cancer, Prehabilitation

In brief

The goal of this prospective, multicenter, open-label randomized controlled clinical trial is to evaluate whether a home-based, digitally supervised multi-modal prehabilitation intervention can improve functional capacity, treatment tolerance, and short- and long-term clinical outcomes in gastric cancer patients who have completed 2-4 cycles of neoadjuvant chemotherapy and are scheduled for radical gastrectomy.

Key facts

Study ID

NCT07755917

Run by

The Affiliated Hospital of Qingdao University

People needed

490

Starts

2026-08-31

Expected to finish

2030-09-01

Last updated by the study team

2026-08-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Aged 18 years or older
• Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1
• Histologically confirmation of gastric or gastroesophageal junction (GEJ) adenocarcinoma. For GEJ carcinomas, eligibility is strictly confined to those presenting with Siewert type III tumors or Siewert type II tumors that do not mandate a concurrent thoracotomy
• Surgery is planned after neoadjuvant therapy
• Capacity to comprehend and voluntarily sign a written informed consent form
• Ability to use digital technology (e.g., smart phones, wearable devices) independently or with the assistance of family members

You may not qualify if…

• Distant metastasis
• Severe cardiac dysfunction (preoperative LVEF < 30% or NYHA classification IV), severe liver dysfunction (Child-Pugh C grade), severe kidney dysfunction (preoperative CRRT was received), ASA grade IV or above; 6MWD ≤ 250 meters
• Within 6 months before enrollment, the patient had experienced cerebral hemorrhage, cerebral infarction, TIA, or suffered from central nervous system diseases or mental disorders, and was unable to cooperate in completing neoadjuvant therapy and prehabilitation
• Presence of severe systemic infections (e.g., multiple organ dysfunction syndrome [MODS]) or active infectious diseases (e.g., tuberculosis)
• Emergency surgery is required due to complications of the tumor (e.g. bleeding, perforation, obstruction)
• Simultaneous tumors or other diseases requiring simultaneous surgery (excluding laparoscopic cholecystectomy)
• Patients who are participating in any other clinical trials (except observational, non-interventional clinical study)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.